Clinical Evidence: What the Trials Actually Show
Which Is Best Wegovy or Mounjaro: Understanding the Key Differences
When comparing which is best wegovy or mounjaro for weight management, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors as a dual agonist. Both treatments work by reducing appetite and promoting feelings of fullness after smaller meals, but they achieve this through different pathways in your body. Understanding these mechanistic differences is crucial when determining which option may be most suitable for your individual circumstances.
The practical implications of choosing which is best wegovy or mounjaro extend beyond just the medication itself. Wegovy has been available in the UK longer, with more extensive real-world usage data and established prescribing patterns among healthcare professionals. Mounjaro represents a newer approach with its dual-action mechanism, though both require the same commitment to lifestyle changes including reduced-calorie diet and increased physical activity. Your prescriber will consider factors including your medical history, current medications, and individual response patterns when helping you decide between these prescription-only medicines.
Wegovy Pricing and Value at EverydayMeds
Understanding the cost structure is essential when deciding which is best wegovy or mounjaro for your budget and treatment timeline. At EverydayMeds, Wegovy pricing starts at £79.99 for the 0.25mg starter dose (weeks 1-4) after applying discount code FIRST40 for new customers or DOSE25 for returning patients. The dose escalation continues with 0.5mg at £94.99 (weeks 5-8), 1mg at £99.99 (weeks 9-12), 1.7mg at £139.99 (weeks 13-16), and the maintenance dose of 2.4mg at £209.99 (weeks 17 onwards). This structured pricing reflects the mandatory dose escalation protocol required for safe and effective treatment.
Our bundle options provide convenient multi-month supply arrangements, such as the Intro Trio (0.25mg, 0.5mg, and 1mg) for £299.99, covering your first three months of treatment. The Ultimate Stability Trio offers three 2.4mg maintenance pens for £649.99, ensuring consistent supply once you reach the therapeutic dose. These bundled arrangements help avoid supply interruptions and reduce the frequency of orders, though individual pen pricing remains competitive. All prices shown are final amounts after applying the appropriate discount codes at checkout through our secure ordering system.
Clinical Evidence: STEP Trial Results for Weight Management
The question of which is best wegovy or mounjaro requires examining the clinical evidence from peer-reviewed trials. In the landmark STEP 1 trial published by Wilding et al. in the New England Journal of Medicine (2021), patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. The STEP 3 trial demonstrated even higher results of approximately 16% when combined with intensive behavioural therapy support.
Long-term sustainability data from STEP 5 showed approximately clinically studied weight loss maintained at two years, while the recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events. These results represent averages from clinical trial populations and individual responses may vary significantly. It's important to note that different trials use varying endpoints and populations, making direct percentage comparisons between Wegovy and Mounjaro inappropriate without considering study design differences.
How Wegovy Works: GLP-1 Mechanism Explained
When evaluating which is best wegovy or mounjaro, understanding how Wegovy functions helps inform your decision. Wegovy contains semaglutide, which acts as a GLP-1 receptor agonist by mimicking glucagon-like peptide-1, a hormone naturally produced in your intestines. This hormone normally signals feelings of fullness and satiety to your brain after eating, but many people with obesity have reduced sensitivity to these natural signals. By activating GLP-1 receptors, Wegovy may help restore normal appetite regulation, reduce food cravings, and promote earlier feelings of fullness during meals. The medication also slows gastric emptying, which means food stays in your stomach longer, contributing to prolonged satisfaction after eating. This comprehensive approach to appetite regulation works alongside your commitment to reduced-calorie eating and increased physical activity to support sustainable weight management.
Streamlined Ordering Process at EverydayMeds
Accessing either option when deciding which is best wegovy or mounjaro starts with our efficient three-minute online clinical assessment, designed to gather essential medical information safely and comprehensively. Our qualified prescribers review your assessment within three working days (or 24 hours with express service), evaluating your suitability for treatment based on MHRA licensing criteria and NICE guidelines. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy (#9012878) and dispatched via temperature-controlled cold-chain delivery for next working day arrival. Our packaging maintains the required 2-8°C storage temperature throughout transit, ensuring your medication arrives in optimal condition. You'll receive tracking information and delivery notifications, plus ongoing support from our clinical team throughout your treatment journey.
Storage and Practical Considerations
A practical advantage when comparing which is best wegovy or mounjaro lies in storage flexibility and convenience factors. Wegovy must be stored in the refrigerator at 2-8°C before first use, but offers superior room temperature stability, remaining effective for up to six weeks below 30°C once removed from refrigeration. This compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy more suitable for travel, work situations, or lifestyle circumstances where consistent refrigeration access may be challenging. The FlexTouch pen delivery system is pre-filled and disposable, requiring no mixing or preparation, with clear dose confirmation through the pen window. Dose escalation follows a fixed schedule over 16 weeks, starting at 0.25mg and increasing every four weeks until reaching the 2.4mg maintenance dose, though some patients may benefit from slower titration based on individual tolerance.
Comparing Dual vs Single Receptor Targeting
The scientific distinction between these treatments helps clarify which is best wegovy or mounjaro for different patient profiles. Wegovy's single GLP-1 receptor targeting provides a well-established mechanism with extensive safety data from multiple patient populations and longer market availability. This focused approach may be preferable for patients who prefer treatments with longer track records and established prescribing patterns among UK healthcare providers. Mounjaro's dual GIP and GLP-1 receptor activation represents a newer therapeutic approach that may theoretically offer additional benefits, though head-to-head comparison trials have not been completed.
Both prescription-only medicines require identical lifestyle commitments including structured dietary changes and regular physical activity to achieve optimal results. Your individual response to either medication cannot be predicted in advance, and some patients may find one treatment more tolerable than the other in terms of side effects or injection experience. The decision of which is best wegovy or mounjaro ultimately depends on factors including your medical history, concurrent medications, lifestyle considerations, and prescriber recommendation based on current clinical guidelines.
Making Your Decision with Expert Support
Rather than determining which is best wegovy or mounjaro independently, our experienced prescribing team can guide you through the decision-making process based on current evidence and your individual circumstances. Both treatments are available through EverydayMeds with the same high standards of clinical assessment, cold-chain delivery, and ongoing support throughout your weight management journey. New customers can apply discount code FIRST40 at checkout, while returning patients use DOSE25 to access our competitive pricing structure. Our GPhC-registered pharmacy (#9012878) ensures compliance with all UK regulations for prescription-only medicines, while our clinical team remains available for guidance throughout your treatment. Whether you choose Wegovy or Mounjaro, success depends on your commitment to the comprehensive lifestyle changes required alongside either medication. Start your assessment today at https://everydaymeds.co.uk/collections/wegovy to begin your evidence-based weight management journey with professional support every step of the way.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
